How Much Does NuVasive Inc. (NUVA) Pay Out In Dividends?


As of Wednesday close, NuVasive Inc.’s (NASDAQ:NUVA) stock was up $0.49, moving up 1.32 percent to $37.63. The average number of shares traded per day over the past five days has been 582,500 shares. 4 times new highs have been achieved over the past 5 days, with a $1.21 gain in that time frame. In the last twenty days, the average volume was 762,995, while in the previous 50 days, it was 706,210.

Since last month, NUVA stock retreated -13.89%. Shares of the company fell to $35.17 on 11/17/22, the lowest level in the past month. A 52-week high of $60.47 was reached on 04/20/22 after having rallying from a 52-week low of $35.17. Since the beginning of this year, NUVA’s stock price has dropped by -28.30% or -$14.85, and marked a new high 10 times. However, the stock has declined by -37.77% since its 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


NUVA stock investors should be aware that NuVasive Inc. (NUVA) stock had its last reported insider trading activity 225 days ago on Apr 13. Barry James Christopher, the Chief Executive Officer of the company, disposed of 5,000 shares for $58.00 on Apr 13. It resulted in a $290,000 divestment by the insider. Barry James Christopher sold 5,000 shares at an average price of $55.00 on Mar 28. The insider now owns 55,218 shares following the transaction.

Valuation Metrics

The stock’s beta is 1.05. Besides these, the trailing price-to-sales (P/S) ratio of 1.61, the price-to-book (PB) ratio of 2.35, and the price-to-cash flow ratio of 71.15 may also be considered.

Financial Health

In the three months ended June 29, NuVasive Inc.’s quick ratio stood at 0.70, while its current ratio was 1.20, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.53, and the total debt-to-equity ratio was 1.07. On the profitability front, the trailing twelve-month gross margin is 72.50% percent. In the year ended June 29, operating margins totaled 3.20%. Based on annual data, NUVA earned $816.71 million in gross profit and brought in $1.14 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -1.10%. Return on equity (ROE) for the past 12 months was -2.50%.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. NUVA’s revenue rose 8.28% to $310.45 million during the quarter, while net income inched up to $295.28 million. While analysts expected NuVasive Inc. to report $0.56 quarterly earnings, the actual figure was $0.47 per share, beating the consensus estimate by -16.10%. During the quarter, the company generated $60.66 million in EBITDA. The liabilities of NuVasive Inc. were 1.34 billion at the end of its most recent quarter ended June 29, and its total debt was $1.01 billion. The value of shareholders’ equity is $52.13 million.

Technical Picture

This quick technical analysis looks at NuVasive Inc.’s (NUVA) price momentum. With a historical volatility rate of 45.33%, the RSI 9-day stood at 43.55% on 23 November.

With respect to its five-day moving average, the current NuVasive Inc. price is up by +3.32% percent or $1.21. At present, NUVA shares trade -14.32% below its 20-day simple moving average and -25.28% percent below its 100-day simple moving average. However, the stock is currently trading approximately -22.06% below its SMA50 and -26.40% below its SMA200.

Stochastic coefficient K was 23.43% and Stochastic coefficient D was 16.02%, while ATR was 1.48. Given the Stochastic reading of 33.06% for the 14-day period, the RSI (14) reading has been calculated as 40.96%. As of today, the MACD Oscillator reading stands at -0.05, while the 14-day reading stands at -0.85.

Analyst Ratings

Barclays launched its rating on NuVasive Inc. (NASDAQ: NUVA) to an Overweight in a note to investors on October 18, 2022. NuVasive Inc. (NUVA) has been rated Overweight by analysts. According to 0 brokerage firms, NUVA is a sell, and 7 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate NuVasive Inc. stock as buy, with 8 recommending it as overweight.


Please enter your comment!
Please enter your name here